Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre J Dilda

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer Cell International|March 28, 2012
The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocaseDanielle Park, Joyce Chiu, Gabriel G Perrone, et al.
The Journal of Biological Chemistry|August 30, 2008
Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acidPierre J Dilda, Emma E Ramsay, Alessandro Corti, et al.
Emerging Microbes & Infections|November 16, 2021
A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortalitySerge Camelo, Mathilde Latil, Sam Agus, et al.
The International Journal of Biochemistry & Cell Biology|December 28, 2007
Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloidPierre J Dilda, Gabriel G Perrone, Amanda Philp, et al.
Oncotarget|February 1, 2020
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomasXiaochun Wang, Reichelle X Yeo, Philip J Hogg, et al.
Journal of Medicinal Chemistry|October 1, 2009
Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosolPierre J Dilda, Stéphanie Decollogne, Lakmini Weerakoon, et al.
Molecular Pharmaceutics|March 25, 2014
Employing pancreatic tumor γ-glutamyltransferase for therapeutic deliveryEmma E Ramsay, Stéphanie Decollogne, Swapna Joshi, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 8, 2023
BIO101 stimulates myoblast differentiation and improves muscle function in adult and old miceMaria Serova, Blaise Didry-Barca, Robin Deloux, et al.
Journal of the Peripheral Nervous System : JPNS|August 20, 2025
Neuroprotective Effect of Mas Activation by BIO101 in Vincristine-Induced Small Fiber NeuropathySimon Frachet, Aurore Danigo, Mathilde Latil, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 14, 2023
A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adultsWaly Dioh, Cendrine Tourette, Susanna Del Signore, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer Cell International|March 28, 2012
The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocaseDanielle Park, Joyce Chiu, Gabriel G Perrone, et al.
The Journal of Biological Chemistry|August 30, 2008
Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acidPierre J Dilda, Emma E Ramsay, Alessandro Corti, et al.
Emerging Microbes & Infections|November 16, 2021
A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortalitySerge Camelo, Mathilde Latil, Sam Agus, et al.
The International Journal of Biochemistry & Cell Biology|December 28, 2007
Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloidPierre J Dilda, Gabriel G Perrone, Amanda Philp, et al.
Oncotarget|February 1, 2020
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomasXiaochun Wang, Reichelle X Yeo, Philip J Hogg, et al.
Journal of Medicinal Chemistry|October 1, 2009
Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosolPierre J Dilda, Stéphanie Decollogne, Lakmini Weerakoon, et al.
Molecular Pharmaceutics|March 25, 2014
Employing pancreatic tumor γ-glutamyltransferase for therapeutic deliveryEmma E Ramsay, Stéphanie Decollogne, Swapna Joshi, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 8, 2023
BIO101 stimulates myoblast differentiation and improves muscle function in adult and old miceMaria Serova, Blaise Didry-Barca, Robin Deloux, et al.
Journal of the Peripheral Nervous System : JPNS|August 20, 2025
Neuroprotective Effect of Mas Activation by BIO101 in Vincristine-Induced Small Fiber NeuropathySimon Frachet, Aurore Danigo, Mathilde Latil, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 14, 2023
A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adultsWaly Dioh, Cendrine Tourette, Susanna Del Signore, et al.
Pageof 4